Site intended for UK
audience
Site intended for UK
audience
Potassium iodide G.L. contains the active substance potassium iodide.
Potassium iodide G.L. 65 mg tablets are used for iodine blockade of the thyroid gland in the event of nuclear accidents (prevention of radioactive iodine [iodine-131] being stored in the thyroid gland).
| Population/age group | Dosage | |
| Pregnant and breastfeeding women: | 2 tablets once | (equivalent to 100 mg iodide) |
| under 1 month: | ¼ tablet once | (quivalent to 12.5 mg iodide) |
| 1 to under 36 months: | ½ tablet | (quivalent to 25 mg iodide) |
| 3 to under 12 years: | 1 tablet | (quivalent to 50 mg iodide) |
| 12 to under 40 years: | 2 tablets | (quivalent to 100 mg iodide) |
| People 40 years and older: | not recommended |
The tablet can be divided into equal doses with the help of a cross-break groove.
A single intake is usually sufficient. In exceptional cases, the competent authority will recommend another tablet intake.
| Strength | Pack size |
| 65 mg | 10 |
We ask for your understanding that due to the Austrian Medicines Act, certain further information is only accessible to medical professionals.
Login
You are currently viewing a placeholder content from Facebook. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Instagram. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou need to load content from hCaptcha to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Turnstile. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from X. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information
